65,437 trials
Metastatic Colorectal Cancer
Primary: Progression-free Survival — 8.6; 8.2 Months
Human Immunodeficiency Virus
Primary: Percentage of Participants With Human Immunodeficiency Virus -1 Ribonucleic Acid (HIV-1 RNA) <50 Copies/mL — 8.6; 26.2; 40.0; 56.3 percentage of participants
Breast Cancer
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events (SAEs) — 24; 11 participants
Castration-Resistant Prostate Cancer
Primary: Overall Survival — 18.4; 13.6 Months — p=<0.0001
Multiple Sclerosis
Primary: Mean Number of Gadolinium (Gd)-Enhanced T1-weighted Lesions at Month 6 (Core) — 2.3; 1.4; 0.4 GD- enhanced T1 lesions
Diabetes Mellitus, Type 1
Primary: Mean of Last Five 7-point Self Monitored Blood Glucose (SMBG) Taken on Day 6 for Insulin Lispro 6D and Day 2 for Insulin Lispro 2D and Day 6 for Insulin Aspart 6D Pump…
Melanoma
Primary: Clinical Responses in Patients With Metastatic Ocular Melanoma — 0; 0; 9; 7 Participants
HIV Infection
Primary: Total Limb Fat Mass — 8.84; 9.13 kg
Extrahepatic Bile Duct Cancer · Nausea · Vomiting
Primary: Number of Patients With Gastrointestinal Toxicities (Grade 3 and 4 Nausea and Vomiting) Associated With Delivering Fluorouracil/Gemcitabine Hydrochloride-based…
Chronic Kidney Disease
Primary: Serum Phosphorus — 3.9; 4.2 mg/dL
Coronary Disease · Heart Diseases · Cardiovascular Diseases
Primary: Cognitive Function — 0.07; 0.12 Continuous cognitive change score
Food Hypersensitivity · Hypersensitivity · Immediate Hypersensitivity
Primary: Percent of Participants Who Successfully Consumed 5,000 mg of Peanut Powder or at Least a 10-fold Increase in the Amount of Peanut Powder Compared to Their Baseline Oral…
Exercise Therapy · Pain
Primary: Six-minute Walk Test — 37.7; 8.6 meter
Burns · Pain
Primary: Overall Pain Trajectory Slopes — -0.22; -0.16 Numeric Rating Scale Score Change/Day
Healthy Volunteers
Primary: Inter-rater Reliability of Physician Raters Using the Global Eyebrow Assessment (GEBA) Scale — 0.889 Kendall's W